Effect of altering smooth muscle tone on maximal expiratory flows in patients with tracheomalacia.

PubWeight™: 1.54‹?› | Rank: Top 4%

🔗 View Article (PMID 1980538)

Published in Pediatr Pulmonol on January 01, 1990

Authors

H B Panitch1, E N Keklikian, R A Motley, M R Wolfson, D V Schidlow

Author Affiliations

1: Department of Pediatrics, St. Christopher's Hospital for Children, Temple University School of Medicine, Philadelphia, Pennsylvania 19134-1095.

Articles by these authors

Pseudomonas cepacia colonization in patients with cystic fibrosis: risk factors and clinical outcome. J Pediatr (1985) 4.26

Something is (not) rotten in Denmark [Hamlet (not) W. Shakespeare]. Pediatr Pulmonol (1997) 3.51

Efficacy of aerosolized tobramycin in patients with cystic fibrosis. N Engl J Med (1993) 3.27

Isolation medium for the recovery of Pseudomonas cepacia from respiratory secretions of patients with cystic fibrosis. J Clin Microbiol (1985) 3.09

Partial liquid ventilation with perflubron in premature infants with severe respiratory distress syndrome. The LiquiVent Study Group. N Engl J Med (1996) 3.06

Ribotype analysis of Pseudomonas cepacia from cystic fibrosis treatment centers. J Pediatr (1988) 2.60

Liquid ventilation of human preterm neonates. J Pediatr (1990) 2.16

Epidemiologic study of cystic fibrosis: design and implementation of a prospective, multicenter, observational study of patients with cystic fibrosis in the U.S. and Canada. Pediatr Pulmonol (1999) 2.05

Effects of partial liquid ventilation with perfluorodecalin in the juvenile rabbit lung after saline injury. Crit Care Med (2000) 1.99

Passive hemolysis by serum and cobra venom factor: a new mechanism inducing membrane damage by complement. Proc Natl Acad Sci U S A (1969) 1.92

A multicenter study of alternate-day prednisone therapy in patients with cystic fibrosis. Cystic Fibrosis Foundation Prednisone Trial Group. J Pediatr (1995) 1.75

Efficacy and safety of short-term administration of aerosolized recombinant human deoxyribonuclease in patients with cystic fibrosis. Am Rev Respir Dis (1993) 1.63

Primary ciliary dyskinesia: a genome-wide linkage analysis reveals extensive locus heterogeneity. Eur J Hum Genet (2000) 1.57

Clinical features, survival rate, and prognostic factors in young adults with cystic fibrosis. Am J Med (1987) 1.54

Arthritis in cystic fibrosis. Arch Dis Child (1984) 1.52

Pulmonary function in hospitalized infants and toddlers with cystic fibrosis. J Pediatr (1998) 1.43

Effects of a developmental physical therapy program on oxygen saturation and heart rate in preterm infants. Phys Ther (1989) 1.38

Pseudomonas cepacia in the hospital setting: lack of transmission between cystic fibrosis patients. J Pediatr (1986) 1.33

Patterns of medical practice in cystic fibrosis: part II. Use of therapies. Investigators and Coordinators of the Epidemiologic Study of Cystic Fibrosis. Pediatr Pulmonol (1999) 1.29

Inadvertent administration of positive end-distending pressure during nasal cannula flow. Pediatrics (1993) 1.21

Liquid ventilation. Pediatr Pulmonol (1992) 1.07

Interaction between chest wall motion and lung mechanics in normal infants and infants with bronchopulmonary dysplasia. Pediatr Pulmonol (1991) 1.06

Immotile cilia syndrome. N Engl J Med (1983) 1.03

Thoracoabdominal asynchrony in infants with airflow obstruction. Am Rev Respir Dis (1990) 1.03

Risk factors for emergence of Stenotrophomonas maltophilia in cystic fibrosis. Pediatr Pulmonol (2000) 1.00

Liquid ventilation: clinical experiences. Biomed Instrum Technol (1999) 0.97

Effects of inspiratory resistive loading on chest wall motion and ventilation: differences between preterm and full-term infants. Pediatr Res (1992) 0.97

Gastroesophageal reflux in the infant with cystic fibrosis. Am J Surg (1985) 0.97

Immediate improvement in lung volume after exogenous surfactant: alveolar recruitment versus increased distention. J Pediatr (1991) 0.95

Further delineation of spondylo-meta-epiphyseal dysplasia, short limb-abnormal calcification type, with emphasis on diagnostic features. Am J Med Genet (1993) 0.95

Liquid ventilation improves pulmonary function, gas exchange, and lung injury in a model of respiratory failure. Ann Surg (1995) 0.92

Obliterative bronchiolitis in children. Chest (1988) 0.90

Airway responsiveness to low inspired gas temperature in preterm neonates. J Pediatr (1991) 0.89

Mechanics and energetics of breathing helium in infants with bronchopulmonary dysplasia. J Pediatr (1984) 0.88

Developmental differences in tracheal cartilage mechanics. Pediatr Res (1989) 0.88

In vivo mechanical properties of the developing airway. Pediatr Res (1989) 0.87

Intra-tracheal delivery strategy of gentamicin with partial liquid ventilation. Respir Med (1999) 0.87

Physiological effects of ventilation with liquid fluorocarbon at controlled temperatures. Undersea Biomed Res (1984) 0.87

Fibrosing colonopathy in children with cystic fibrosis. J Pediatr Surg (1997) 0.86

Measuring clinical status in cystic fibrosis: internal validity and reliability of a modified NIH score. Pediatr Pulmonol (1994) 0.86

Bronchiolitis in children. Clin Chest Med (1993) 0.86

Cold perfluorochemical-induced hypothermia protects lung integrity in normal rabbits. Biol Neonate (2004) 0.86

Neonatal gastric intubation: differential respiratory effects between nasogastric and orogastric tubes. Pediatr Pulmonol (1990) 0.86

Brain-stem auditory evoked responses to hypercarbia in preterm infants. Electroencephalogr Clin Neurophysiol (1994) 0.86

Liquid ventilation: an alternative ventilation strategy for management of neonatal respiratory distress. Eur J Pediatr (1996) 0.85

Combined gas ventilation and perfluorochemical tracheal instillation as an alternative treatment for lethal congenital diaphragmatic hernia in lambs. J Pediatr Surg (1995) 0.84

Mechanics and energetics of breathing in newly diagnosed infants with cystic fibrosis: effect of combined bronchodilator and chest physical therapy. Pediatr Pulmonol (1989) 0.84

Effect of nasal CPAP on thoracoabdominal motion in neonates with respiratory insufficiency. Pediatr Pulmonol (1991) 0.84

Maturational changes in airway smooth muscle structure-function relationships. Pediatr Res (1992) 0.84

Structural changes in the tracheae of preterm lambs induced by ventilation. Pediatr Res (1989) 0.84

Possible nosocomial transmission of Pseudomonas cepacia in patients with cystic fibrosis. Arch Pediatr Adolesc Med (1994) 0.84

Patterns of medical practice in cystic fibrosis: part I. Evaluation and monitoring of health status of patients. Investigators and Coordinators of the Epidemiologic Study of Cystic Fibrosis. Pediatr Pulmonol (1999) 0.84

Liquid assisted ventilation: an alternative ventilatory strategy for acute meconium aspiration injury. Pediatr Pulmonol (1996) 0.84

Thermal stability and transition studies with a hybrid warming device for neonates. J Perinatol (2001) 0.84

Positive end-expiratory pressure modulates perfluorochemical evaporation from the lungs. Biol Neonate (2003) 0.83

Safety of repeated intermittent courses of aerosolized recombinant human deoxyribonuclease in patients with cystic fibrosis. J Pediatr (1997) 0.83

Lung lavage with oxygenated perfluorochemical liquid in acute lung injury. Crit Care Med (1993) 0.83

Self-management of cystic fibrosis: short-term outcomes of the Cystic Fibrosis Family Education Program. Health Educ Behav (1997) 0.82

Respiratory muscle function, assessment, and training. Phys Ther (1981) 0.82

Liquid ventilation in premature lambs: uptake, biodistribution and elimination of perfluorodecalin liquid. Reprod Fertil Dev (1996) 0.81

Halothane administration during liquid ventilation. Respir Med (1997) 0.81

Use of a touch sensitive screen and computer assisted image analysis for quantitation of developmental changes in pulmonary structure. Pediatr Pulmonol (1990) 0.81

Liquid ventilation of preterm baby. Lancet (1989) 0.80

A comparison of intratracheal and intravenous administration of gentamicin during liquid ventilation. Eur J Pediatr (1997) 0.80

Intratracheal administration of perfluorochemical-gentamicin suspension: a comparison to intravenous administration in normal and injured lungs. Pediatr Pulmonol (2001) 0.80

Structure-function of airway generations 0 to 4 in the preterm lamb. Pediatr Res (1992) 0.79

Effect of tracheal smooth muscle tone on collapsibility of immature airways. J Appl Physiol (1985) (1988) 0.79

Increased respiratory drive and limited adaptation to loaded breathing in bronchopulmonary dysplasia. Pediatr Res (1992) 0.79

A perfluorochemical loss/restoration (L/R) system for tidal liquid ventilation. Biomed Instrum Technol (2001) 0.79

Polysplenia and kartagener syndromes in a sibship: association with abnormal respiratory cilia. J Pediatr (1982) 0.79

Chiari type I malformation in children and adolescents with cystic fibrosis. Pediatr Pulmonol (2000) 0.79

Influence of smooth muscle tone and longitudinal tension on the collapsibility of immature airways. Pediatr Pulmonol (1988) 0.79

Pulmonary administration of gentamicin during liquid ventilation in a newborn lamb lung injury model. Pediatrics (1997) 0.79

Partial liquid ventilation in critically ill infants receiving extracorporeal life support. Philadelphia Liquid Ventilation Consortium. Pediatrics (1997) 0.79

Physiologic, biochemical, and histologic correlates associated with tidal liquid ventilation. Pediatr Res (1998) 0.79

Developmental changes in tracheal structure. Pediatr Res (1991) 0.79

Liquid ventilation: current status. Pediatr Rev (1999) 0.79

Liquid-assisted ventilation: physiology and clinical application. Ann Med (1997) 0.79

A comparison of surfactant delivery with conventional mechanical ventilation and partial liquid ventilation in meconium aspiration injury. Respir Med (2001) 0.79

A comparison of preterm and adult airway smooth muscle mechanics. J Appl Physiol (1985) (1989) 0.79

Effects of CPAP on lung mechanics in infants with acquired tracheobronchomalacia. Am J Respir Crit Care Med (1994) 0.79

Feasibility of lung cancer hyperthermia using breathable perfluorochemical (PFC) liquids. Part II: Ultrasound hyperthermia. Int J Hyperthermia (2004) 0.78

Quantitative structure-activity relationships of perfluorinated hetero-hydrocarbons as potential respiratory media. Application to oxygen solubility, partition coefficient, viscosity, vapor pressure, and density. ASAIO J (1997) 0.78

Quantitative bronchoscopic assessment of airway collapsibility in newborn lamb tracheae. Pediatr Res (1998) 0.78

Enhanced distribution of adenovirus-mediated gene transfer to lung parenchyma by perfluorochemical liquid. Hum Gene Ther (1997) 0.78

Software for real-time control of a tidal liquid ventilator. Biomed Instrum Technol (1999) 0.78

Oxygen consumption and carbon dioxide production during liquid ventilation. J Pediatr Surg (1993) 0.78

Perfluorochemical liquids modulate cell-mediated inflammatory responses. Crit Care Med (2001) 0.78

Effects of perfluorochemical distribution and elimination dynamics on cardiopulmonary function. J Appl Physiol (1985) (2001) 0.78

Effect of oxygen on right ventricular performance evaluated by radionuclide angiography in two young patients with chronic lung disease. Pediatr Pulmonol (1987) 0.78

Meconium aspiration injury: Uncoupling between the in vivo physiologic and in vitro inflammatory responses. Pediatr Crit Care Med (2001) 0.78

Epithelial modulation of preterm airway smooth muscle contraction. J Appl Physiol (1985) (1993) 0.77

Comparison of natural surfactant and brief liquid ventilation rescue treatment in very immature lambs. Clinical and physiological correlates. Biol Neonate (1996) 0.77

Trypsin binding activity of alpha 2-macroglobulin in cystic fibrosis and other lung diseases. Am Rev Respir Dis (1980) 0.77

Effect of ventilation on mechanical properties and pressure-flow relationships of immature airways. Pediatr Res (1988) 0.77

Analysis of perfluorochemical elimination from the respiratory system. J Appl Physiol (1985) (1997) 0.77

Liquid ventilation. Semin Perinatol (2000) 0.77